SCHEMBL3265763

SCHEMBL3265763

C=CCN([O])CC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1497520 0.71 TSHR (0.41)
SCHEMBL2334872 0.69
SCHEMBL7177724 0.67 ALDH1A1 (0.35)
SCHEMBL7549527 0.67 TSHR (0.43)
SCHEMBL11070461 0.67 ALDH1A1 (0.35)
SCHEMBL20656 0.67 TSHR (0.43)
Formaldehyde SCHEMBL11036055 0.65 PYCR1 (0.41)
SCHEMBL324883 0.65
SCHEMBL24833 0.65
SCHEMBL2417531 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1736052-B1 Stem/leaf desiccant SUMITOMO CHEMICAL CO (JP) 2010-04-21 EP claimed
US-20090264412-A1 Combination Therapy Using An 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor And A Glucocorticoid Receptor Agonist To Minimize The Side Effects Associated With Glucocorticoid Receptor Agonist Therapy HIGH POINT PHARMACEUTICALS, LLC (US) 2009-10-22 US claimed
US-20090137574-A1 Combination Therapy Using an 11Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor and an Antihypertensive Agent for the Treatment of Metabolic Syndrome and Related Diseases and Disorders NOVO NORDISK A/S (DK) 2009-05-28 US claimed
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines NOVO NORDISK A/S (DK) 2007-11-22 US claimed
EP-1782859-A2 Pharmaceutical use of substituted pyrazolo [1,5- a]pyrimidines NOVO NORDISK A/S (DK) 2007-05-09 EP claimed
EP-1397958-B1 STEM/LEAF DESICCANT SUMITOMO CHEMICAL CO (JP) 2007-01-10 EP claimed
EP-1342735-B1 Process for the production of high-solids coatings resins via controlled radical polymerisation ARKEMA INC (US) 2006-12-20 EP claimed
US-20060111348-A1 Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders NOVO NORDISK A/S (DK) 2006-05-25 US claimed
US-20060094699-A1 Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy HIGH POINT PHARMACEUTICALS, LLC 2006-05-04 US claimed
EP-1615697-A2 NEW PYRAZOLO[1,5-A] PYRIMIDINE DERIVATIVES AND PHARMACEUTICAL USE THEREOF NOVO NORDISK A/S (DK) 2006-01-18 EP claimed
WO-2004089416-A2 COMBINATION OF AN 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND AN ANTIHYPERTENSIVE AGENT NOVO NORDISK A/S (DK) 2004-10-21 WO claimed
WO-2004089471-A2 NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF NOVO NORDISK A/S (DK) 2004-10-21 WO claimed
WO-2004089415-A2 COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST NOVO NORDISK A/S (DK) 2004-10-21 WO claimed
EP-0951468-A4 SILICONE MONOMERS AND OLIGOMERS HAVING A CARBOXYL FUNCTIONAL GROUP THEREON MONA INDUSTRIES INC (US) 2001-06-06 EP claimed
US-6093829-A Silicone monomers and oligomers having a carboxyl functional group thereon MONA INDUSTRIES, INC. (US) 2000-07-25 US claimed
EP-0951468-A1 SILICONE MONOMERS AND OLIGOMERS HAVING A CARBOXYL FUNCTIONAL GROUP THEREON MONA INDUSTRIES, INC. (US) 1999-10-27 EP claimed
US-5780639-A COUPLING AGENTS, ADHESION PROMOTERS, CROSSLINKING AGENTS MONA INDUSTRIES, INC. (US) 1998-07-14 US claimed
WO-1998022478-A1 SILICONE MONOMERS AND OLIGOMERS HAVING A CARBOXYL FUNCTIONAL GROUP THEREON MONA INDUSTRIES, INC. (US) 1998-05-28 WO claimed
EP-0520880-A1 Cephalosporines having a 2-thia cephem ring, process for their preparation, pharmaceutical compositions containing them, their application as medicaments and intermediates ROUSSEL UCLAF (FR) 1992-12-30 EP claimed
EP-0028449-A1 Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them BEECHAM GROUP PLC (GB) 1981-05-13 EP claimed